Cancer
Immune checkpoint inhibitors
Antibodies that release the brakes on T cells (PD-1, PD-L1, CTLA-4) so the immune system attacks the tumour; they transformed melanoma, renal cell, lung and liver cancer and Hodgkin lymphoma, but can trigger autoimmune damage to any organ.
آلية العمل
- Tumours exploit checkpoints that normally prevent autoimmunity: PD-L1 on tumour cells switches off T cells through PD-1, and CTLA-4 limits T-cell priming.
- Pembrolizumab and nivolumab block PD-1; atezolizumab and durvalumab block PD-L1; ipilimumab blocks CTLA-4.
- T cells that recognise tumour antigens are reactivated and kill tumour cells; responses can last for years.
- The same release can unleash T cells against normal tissues: immune-related adverse events.
الأهداف الجزيئية
- PD-1 (T cells) / PD-L1 (tumour cells): Blocking antibody
- CTLA-4: Blocking antibody
أدوية Immune checkpoint inhibitors
Anti-PD-1
- Pembrolizumab (Anti-PD-1.)
- Nivolumab (Anti-PD-1.)
Anti-PD-L1
- Atezolizumab (Anti-PD-L1.)
Anti-CTLA-4
- Ipilimumab (Anti-CTLA-4, often with nivolumab.)
الاستخدامات العلاجية
- Advanced melanoma
- Advanced renal cell carcinoma
- Non-small cell lung cancer
- Advanced hepatocellular carcinoma
- Relapsed Hodgkin lymphoma
الأمراض التي يعالجها
الآثار الجانبية
- Immune-related colitis, hepatitis and pneumonitis
- Endocrinopathies: thyroiditis, hypophysitis, adrenal insufficiency, type 1 diabetes
- Rash and vitiligo
- Myocarditis and nephritis (rare but serious)
موانع الاستعمال حسب الحالة
- Ulcerative colitis (بحذر): Releasing T cells can make the autoimmune disease flare severely.
- Psoriasis (بحذر): It can flare.
- Organ transplant (بحذر): Releasing T cells can cause rejection.
محاذير وتداخلات أخرى
- Immune-related events are treated with corticosteroids and pausing the drug.
موضوعات مرتبطة
مكتوب من
- Lippincott Illustrated Reviews: Pharmacology, 7th ed., Ch. 35, Anticancer Drugs, Monoclonal antibodies: immune checkpoint inhibitors
- Basic & Clinical Pharmacology (Katzung), 14th ed., Ch. 54, Cancer Chemotherapy, Immune checkpoint inhibitors
- Basic & Clinical Pharmacology (Katzung), 14th ed., Ch. 55, Immunopharmacology, Immune checkpoint inhibitors
مرجع تعليمي، وليس استشارة طبية أو تشخيصاً أو علاجاً.